Certus 140
Payments companies reported to CMS as associated with Certus 140. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Certus 140, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Certus 140
These are the largest totals companies reported as associated with Certus 140. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Short | Pittsburgh, PA | Diagnostic Radiology | $237,701.72 |
| Eric Jensen | Minneapolis, MN | Surgical Oncology | $119,739.34 |
| Peter Dipasco | Saint Louis, MO | Surgical Oncology | $74,051.26 |
| Robert Suh | Los Angeles, CA | Diagnostic Radiology | $55,660.90 |
| Joshua Kuban | Houston, TX | Vascular & Interventional Radiology | $41,317.03 |
| Shane Wells | Ann Arbor, MI | Diagnostic Radiology | $39,705.70 |
| Jayson Brower | Spokane, WA | Vascular & Interventional Radiology | $31,881.00 |
| Edwin Abel | Madison, WI | Urology | $18,900.00 |
| Roger Williams | Marietta, GA | Vascular & Interventional Radiology | $14,183.14 |
| Edward Kim | New York, NY | Vascular & Interventional Radiology | $10,375.51 |
Prescribed Certus 140?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.